InvestorsHub Logo
Followers 8
Posts 2018
Boards Moderated 0
Alias Born 07/19/2006

Re: atheroprevent post# 36419

Monday, 03/21/2011 10:44:25 PM

Monday, March 21, 2011 10:44:25 PM

Post# of 52262
I'm in favor of Neuro's outsourcing approach... ie I would like the Sickle Crisis issue to be wound up in a good RD partnership, but with a caveat or two.

1. If it wouldn't harm a RD deal....
2. More important, might A Sickle Cell foundation type of structure be a source of advancing CX717? ala MJ Fox.

Especially if 2. might be true. Say Cortex can raise 5-6 million by a foundation or say even 2 million by a Sickle Cell Disease foundation, that would be enough to fund a phase IIa small trial. Then, it makes sense.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News